ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,481 | -35.4% | 4,012 | -9.1% | 0.05% | -33.8% |
| Q2 2023 | $124,547 | +43.0% | 4,415 | -12.8% | 0.07% | +54.2% |
| Q1 2023 | $87,118 | -38.3% | 5,065 | -27.7% | 0.05% | -35.1% |
| Q4 2022 | $141,181 | +35.8% | 7,010 | +45.5% | 0.07% | +80.5% |
| Q3 2022 | $104,000 | -22.4% | 4,819 | +0.7% | 0.04% | -18.0% |
| Q2 2022 | $134,000 | +34.0% | 4,786 | +120.7% | 0.05% | +11.1% |
| Q1 2022 | $100,000 | -48.5% | 2,169 | -5.9% | 0.04% | -38.4% |
| Q4 2021 | $194,000 | -23.3% | 2,305 | -39.2% | 0.07% | -34.2% |
| Q3 2021 | $253,000 | +19.3% | 3,794 | -5.0% | 0.11% | +27.6% |
| Q2 2021 | $212,000 | -15.9% | 3,992 | -31.4% | 0.09% | -17.9% |
| Q1 2021 | $252,000 | -15.2% | 5,819 | +1.9% | 0.11% | -13.8% |
| Q4 2020 | $297,000 | – | 5,711 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |